Infant and toddler diabetes

Archives of Disease in Childhood

Volumn 92, Issue 8, 2007, Pages 716-719

  Cody, Declan ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA;

CHILD CARE; CHILD PARENT RELATION; DIABETIC KETOACIDOSIS; DRUG EFFICACY; FAMILY FUNCTIONING; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFANT DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MORBIDITY; PRIORITY JOURNAL; REVIEW; TODDLER;

AUTOANTIBODIES; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; EATING; FAMILY; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INFANT; INSULIN; IRELAND; PARENTS;

EID: 34547699658     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.112896     Document Type: Review

References (41)

1. Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk haplotypes. Lancet 2004;364:1699-1700.
2. Rasgasamai JJ, Greenwood DC, McSporran B, et al. Rising incidence of type 1 diabetes in Scottish children, 1984-93. The Scottish Study Group for the Care of Young Diabetics. Arch Dis Child 1997;77(3):210-13.
3. Dahlquist G, Hustonen L. Analysis of a 15 year prospective incidence study of childhood diabetes onset: time trends and climatological factors. Int J Epidemiol 1994;23:1234-41.
4. Gardner SG, Bingley PJ, Satwell PA, et al. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Barts-Oxford Study Group. BMJ 1997;315:713-7.
5. The Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-86.
7. Nordfeldt S, Ludvigsson J. Adverse events in intensively treated children and adolescents with type 1 diabetes. Acta Paediatr 1999;88:1184-93.
8. Swift PGF. Insulin treatment at onset of diabetes. Horm Res 2002;57(1):93-6.
9. Komulainen J, Kulmala P, Savola K. Clinical, autoimmune and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999;22:1950-5.
10. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset and development of microvascular complications in childhood-onset type 1 diabetes. Diabetes Care 2004;27(4):955-62.
11. Donaghue KC, Fung AT, Hing S, et al. The effect of prepubertal diabetes duration on diabetes. Microvascular complications in early and late adolescence. Diabetes Care 1997;20:77-80.
12. Holl RW, Lang GE, Grabert M, et al. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. Pediatrics 1998;132:790-4.
13. Edge JA, Swift PGF, Anderson W, et al. Diabetes services in the UK: fourth national survey: are we meeting NSF standards and NICE guidelines? Arch Dis Child 2005;90:1005-9.
14. Paul P, Ghatak A, Kerr S, et al. Severe metabolic decompensation at presentation of diabetes mellitus in children aged <2 years. Arch Dis Child 2005;90:A19-22.
15. Muhammad BJ, Swift PGF, Raymond NT, et al. Partial remission phase of diabetes in children younger than age 10 years. Arch Dis Child 1999;80:367-9.
16. Raine JE, Donaldson MDC, Gregory JW, et al. Practical endocrinology and diabetes in children, 2nd edn. Oxford: Blackwell, 2006:1-33.
17. Diabetes Australia. Parents & carers. Information for parents of kids aged 0-2 years. http://www.diabeteskidsandteens.com.au (accessed 8 March 2007).
18. Kushion W, Salisbury PJ, Seitz KW. Issues in the care of infants and toddlers with insulin dependent diabetes mellitus. Diabetes Educ 1991;17(2):107-10.
19. Anderson BJ. Children with diabetes mellitus and family functioning: translating research into practice. J Pediatr Endocrinol Med 2001;14:645-52.
20. Wysocki T, Huxtable K, Linscheid TR. Adjustment to diabetes mellitus in pre-schoolers and their mothers. Diabetes Care 1989;12(8):524-9.
21. Hatton DL, Canam CC, Thorne S, et al. Parents perceptions of caring for an infant or toddler with diabetes. J Adv Nurs 1995;22:569-77.
22. Deiss D, Kordonouri K, Meyer K, et al. Long hypoglycaemic periods detected by subcutaneous continuous glucose monitoring in toddlers and pre-school children with diabetes mellitus. Diabetic Med 2001;18:333-8.
23. Lteif AN, Schwenk WF. Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycaemic reactions. Mayo Clin Proc 1999;74:211-16.
24. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes in early life. Pediatrics 1985;75:921-7.
25. Rovet JF, Ehrlich RM. The effect of hypoglycaemic seizures on cognitive function in children with diabetes: a seven year prospective study. J Pediatr 1999;134:503-6.
26. Hershey T, Bhargava, N, Sadler M, et al. Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care 1999;22(8):1318-24.
27. Northam EA, Anderson PJ, Jacobs R, et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001;24(9):1541-7.
28. Silverstein J, Klingensmith K, Copeland L. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28(1):186-212.
29. Kiess W, Kapellen T, Siebler T, et al. Practical aspects of managing preschool children with type 1 diabetes. Acta Paediatr 1998;425:67-71.
30. Hathout EH, Fujishige L, Geach J, et al. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children and adolescents with diabetes. Diabetes Technol Ther 2003;5(5):801-6.
31. Dixon B, Chase HA, Burdick J, et al. Use of insulin glargine in children under age 6 with type 1 diabetes. Pediatr Diabetes 2005;6(3):150-4.
32. Rutledge KS, Chase HP, Klingensmith GJ, et al. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 1997;100(6):968-72.
33. Winzimer SA, Swan KL, Sikes KA, et al. Emerging evidence for the use of insulin pump therapy in infants, toddlers and pre-school children with type 1 diabetes. Pediatr Diabetes 2006;7(4):15-19.
34. Ahern JH, Boland EA, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002;3:10-15.
35. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes is safe and effective. Pediatr Diabetes 2005;6(1):17-21.
36. Fox LA, Buckloh LM, Smith SD, et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005;28(6):1277-81.
37. DiMeglio LA, Pottorff TM, Boyd SR, et al. A randomized controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145:380-4.
38. Eugster EA, Francis G. Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006;118(4):1244-9.
39. National Institute for Clinical Excellence (NICE). Guidance on the use of continuous subcutaneous insulin infusion for diabetes, Technology appraisal guidance no 57. London, UK: NICE, 2003.
40. Pearson ER, Fletchner I, Njolstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355(5):467-76.
41. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes. Diabetes 2005;54:2503-15.